These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26362697)

  • 1. Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex.
    Somani S; Robb G; Pickard BS; Dufès C
    J Control Release; 2015 Nov; 217():235-42. PubMed ID: 26362697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain.
    Somani S; Blatchford DR; Millington O; Stevenson ML; Dufès C
    J Control Release; 2014 Aug; 188():78-86. PubMed ID: 24933602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12.
    Altwaijry N; Somani S; Parkinson JA; Tate RJ; Keating P; Warzecha M; Mackenzie GR; Leung HY; Dufès C
    Drug Deliv; 2018 Nov; 25(1):679-689. PubMed ID: 29493296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential liver gene expression with polypropylenimine dendrimers.
    Schatzlein AG; Zinselmeyer BH; Elouzi A; Dufes C; Chim YT; Roberts CJ; Davies MC; Munro A; Gray AI; Uchegbu IF
    J Control Release; 2005 Jan; 101(1-3):247-58. PubMed ID: 15588909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.
    Koppu S; Oh YJ; Edrada-Ebel R; Blatchford DR; Tetley L; Tate RJ; Dufès C
    J Control Release; 2010 Apr; 143(2):215-21. PubMed ID: 19944722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex.
    Aldawsari H; Edrada-Ebel R; Blatchford DR; Tate RJ; Tetley L; Dufès C
    Biomaterials; 2011 Sep; 32(25):5889-99. PubMed ID: 21596431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells.
    Almowalad J; Laskar P; Somani S; Meewan J; Tate RJ; Dufès C
    Int J Nanomedicine; 2022; 17():1409-1421. PubMed ID: 35369035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.
    Lim LY; Koh PY; Somani S; Al Robaian M; Karim R; Yean YL; Mitchell J; Tate RJ; Edrada-Ebel R; Blatchford DR; Mullin M; Dufès C
    Nanomedicine; 2015 Aug; 11(6):1445-54. PubMed ID: 25933695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells.
    Somani S; Laskar P; Altwaijry N; Kewcharoenvong P; Irving C; Robb G; Pickard BS; Dufès C
    Sci Rep; 2018 Jun; 8(1):9410. PubMed ID: 29925967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents.
    Zinselmeyer BH; Mackay SP; Schatzlein AG; Uchegbu IF
    Pharm Res; 2002 Jul; 19(7):960-7. PubMed ID: 12180548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.
    Lemarié F; Croft DR; Tate RJ; Ryan KM; Dufès C
    Biomaterials; 2012 Mar; 33(9):2701-9. PubMed ID: 22200536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.
    Zarebkohan A; Najafi F; Moghimi HR; Hemmati M; Deevband MR; Kazemi B
    Eur J Pharm Sci; 2015 Oct; 78():19-30. PubMed ID: 26118442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery.
    Russ V; Günther M; Halama A; Ogris M; Wagner E
    J Control Release; 2008 Dec; 132(2):131-40. PubMed ID: 18812195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.
    Al Robaian M; Chiam KY; Blatchford DR; Dufès C
    Nanomedicine (Lond); 2014 Apr; 9(4):421-34. PubMed ID: 24910874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells.
    Laskar P; Somani S; Mullin M; Tate RJ; Warzecha M; Bowering D; Keating P; Irving C; Leung HY; Dufès C
    Biomater Sci; 2021 Feb; 9(4):1431-1448. PubMed ID: 33404026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type.
    Omidi Y; Hollins AJ; Drayton RM; Akhtar S
    J Drug Target; 2005 Aug; 13(7):431-43. PubMed ID: 16308212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles.
    Huang R; Ke W; Han L; Liu Y; Shao K; Ye L; Lou J; Jiang C; Pei Y
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1914-23. PubMed ID: 19654588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.
    Huang R; Ke W; Liu Y; Jiang C; Pei Y
    Biomaterials; 2008 Jan; 29(2):238-46. PubMed ID: 17935779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo.
    Huang R; Ke W; Han L; Liu Y; Shao K; Jiang C; Pei Y
    Brain Res Bull; 2010 Apr; 81(6):600-4. PubMed ID: 20026388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.